Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
This study is ongoing, but not recruiting participants.
Study NCT00478465
Information provided by Stanford University
First Received: May 23, 2007
Last Updated: August 29, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
